Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

  1. Dalbeth, N.
  2. Jones, G.
  3. Terkeltaub, R.
  4. Khanna, D.
  5. Kopicko, J.
  6. Bhakta, N.
  7. Adler, S.
  8. Fung, M.
  9. Storgard, C.
  10. Baumgartner, S.
  11. Perez-Ruiz, F.
Zeitschrift:
Arthritis and Rheumatology

ISSN: 2326-5205,  2326-5191

Datum der Publikation: 2017

Ausgabe: 69

Nummer: 9

Seiten: 1903-1913

Art: Artikel

DOI: 10.1002/ART.40159 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus